Invasive Fungal Infections: Host-Pathogen Interaction, ESCMID Postgraduate Education Course
16 - 17 March 2010, Oslo, Norway
Organizers
Jointly organized by the ESCMID Fungal Infection Study Group (EFISG), the Antifungal Susceptibility Testing Subcommittee of th European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) and the Nordic Society of Medical Mycology (NSMM).
Course Objectives
The course will provide participants with a review on biological characteristics, including virulence factors, of the most common medically important fungi. In addition, you are updated on the host immune response to these pathogens and future perspectives will be discussed. This is presented with state-of-the-art lectures combined with shorter, more detailed presentations.
Course Venue
Institute of Medical Microbiology, Rikshospitalet University Hospital, Sognsvannsveien 20, Oslo, Norway.
This course directly precedes the meeting of the Nordic Society of Medical Mycology.
Target Audience
Medical doctors, scientists, clinical microbiologists or pharmacists, involved in diagnosis, prophylaxis and treatment of invasive fungal infections. Junior staff members are strongly encouraged to apply.
Registration Procedure
Please download the registration form (see right column) and return it to the course administrative secretariat by 15 March 2010.
Registration Fee
EUR 250 for ESCMID / NSMM members
EUR 300 for all others
The fee includes the scientific sessions, printed course material, lunches and coffee breaks, social programme, but not travel and accommodation.
Attendance Grants
ESCMID provides a number of attendance grants for young attendees (born in 1970 or later) covering the registration fee, but no travel or accommodation costs. Please submit your application until 19 February 2010 online on this website (see right column). If there are more applicants than available grants, preference will be given to ESCMID members. Applicants will be informed about their acceptance by 26 February 2010.
Second round of Grant Applications! New Deadline: 19 February 2010
Please note that attendance grant application does not include registration for the course. Please register separately with the form supplied on the right.
CME Accreditation
The organizer of the course will apply for European CME accreditation through EACCME.
Administrative Secretariat
Institute of Medical Microbiology
Rikshospitalet University Hospital
Sognsvannsveien 20
N-0027 Oslo, Norway
Phone +47 230 71100
Fax +47 230 71110
Peter Gaustad
Peter Gaustad
Phone +47 230 71167
Ingvild Nordøy
Ingvild Nordoy
Phone +47 230 71158
Course Programme
16 March 2010
11.30 Welcome. P. Gaustad
11.40 LUNCH
Biological characteristics of medically important fungi:
12.30 What is a fungus – in Darwin's perspective. T. Schumacher
13.00 Cryptococcus. T. Schumacher
13.30 Pneumocystis jirovecii. P. Gaustad
14.00 BREAK
14.15 Candida. I. Nordøy
14.45 Zygomycetes. E. Roilides
15.15 BREAK
Virulence factors in pathogenic fungus
15.30 Various virulence factors. T. Abrahamsen
16.10 Biofilm. G. Ramage
16.40 The effect of gliotoxin on T-cells. C. Torp Andersen, P. Gaustad & T. Abrahamsen
17.00 BREAK
The immune response in fungal infection: protective or pathogenic responses?
17.15 The first encounter: pathogen recognition. A. Warris
18.00 TLR5 and Aspergillus infection. K. Rødland
18.20 Dectin-1 and Dectin-2 receptors and fungi. M. Daws
18:40 End of Day
19:30 Dinner
17 March 2010
Biological characteristics of medically important fungi:
09.00 Aspergillus – biological characteristics. D. Denning
The immune response in fungal infection: protective or pathogenic responses?
09.30 Cells and cytokines of the innate immune system in fungal infections. E. Roilides
10.10 Immunopathogenesis in Aspergillus infection. D. Denning
10.50 BREAK
11.05 The role of platelets in Aspergillus infection. K. Rødland, T. Ueland, T.M. Pedersen, B.Halvorsen, F. Müller, P. Aukrust & S.S. Frøland
11.25 T-cells, L. Romani
12.20 LUNCH
13.20 Impact of antifungals on the pathogen and the host. P. E. Verweij
14.10 Colonisation vs. invasion. P. Gaustad
14.40 Colonisation in the neonate. E. Kvadsheim, T. Abrahamsen & P. Gaustad
15.00 BREAK
15.15 Immunotherapy – the future? S.S. Frøland
16.00 End of Course
Faculty
- T. Abrahamsen, Oslo, Norway
- P. Aukrust, Oslo, Norway
- M. Daws, Oslo, Norway
- D. Denning, Manchester, UK
- S.S. Frøland, Oslo, Norway
- P. Gaustad, Oslo, Norway
- B. Halvorsen, Oslo, Norway
- E. Kvadsheim, Oslo, Norway
- F. Müller, Oslo, Norway
- I. Nordøy, Oslo, Norway
- T.M. Pedersen, Oslo, Norway
- G. Ramage, Glasgow, UK
- E. Roilides, Thessaloniki, Greece
- K. Rødland, Oslo, Norway
- L. Romani, Perugia, Italy
- T. Schumacher, Oslo, Norway
- C. Torp Andersen, Oslo, Norway
- T. Ueland, Oslo, Norway
- P. E. Verweij, Nijmegen, The Netherlands
- A. Warris, Nijmegen, The Netherlands
